These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26021076)

  • 1. [Overview of Ebola virus vaccine].
    Yang L; Li J; Gao GF; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2015 Jan; 31(1):1-23. PubMed ID: 26021076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 3. An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.
    Wu S; Kroeker A; Wong G; He S; Hou L; Audet J; Wei H; Zhang Z; Fernando L; Soule G; Tran K; Bi S; Zhu T; Yu X; Chen W; Qiu X
    J Infect Dis; 2016 Oct; 214(suppl 3):S326-S332. PubMed ID: 27493239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease.
    Wang H; Wong G; Zhu W; He S; Zhao Y; Yan F; Rahim MN; Bi Y; Zhang Z; Cheng K; Jin H; Cao Z; Zheng X; Gai W; Bai J; Chen W; Zou Y; Gao Y; Gao GF; Yang S; Xia X; Qiu X
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
    Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
    mBio; 2019 May; 10(3):. PubMed ID: 31138743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vesicular stomatitis virus expressing Ebola virus glycoprotein (rVSV-EBOV), a new Ebola vaccine.
    Kasereka MC; Mumtaz Z; Hawkes MT
    Drugs Today (Barc); 2021 Jan; 57(1):27-45. PubMed ID: 33594388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.
    Marzi A; Hanley PW; Haddock E; Martellaro C; Kobinger G; Feldmann H
    J Infect Dis; 2016 Oct; 214(suppl 3):S360-S366. PubMed ID: 27496978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates.
    Marzi A; Feldmann F; O'Donnell KL; Hanley PW; Messaoudi I; Feldmann H
    J Infect Dis; 2023 Nov; 228(Suppl 7):S671-S676. PubMed ID: 37290042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ebola Virus: Pathogenesis and Countermeasure Development.
    Furuyama W; Marzi A
    Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.
    Marzi A; Robertson SJ; Haddock E; Feldmann F; Hanley PW; Scott DP; Strong JE; Kobinger G; Best SM; Feldmann H
    Science; 2015 Aug; 349(6249):739-42. PubMed ID: 26249231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward an Effective Ebola Virus Vaccine.
    Keshwara R; Johnson RF; Schnell MJ
    Annu Rev Med; 2017 Jan; 68():371-386. PubMed ID: 27686015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the development of vaccines for Ebola virus disease.
    Ohimain EI
    Virus Res; 2016 Jan; 211():174-85. PubMed ID: 26596227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates.
    Marzi A; Halfmann P; Hill-Batorski L; Feldmann F; Shupert WL; Neumann G; Feldmann H; Kawaoka Y
    Science; 2015 Apr; 348(6233):439-42. PubMed ID: 25814063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies.
    Ravichandran S; Khurana S
    EBioMedicine; 2022 Aug; 82():104186. PubMed ID: 35901660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments and strategies of Ebola virus vaccines.
    Sharma AR; Lee YH; Nath S; Lee SS
    Curr Opin Pharmacol; 2021 Oct; 60():46-53. PubMed ID: 34329960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques.
    Marzi A; Fletcher P; Feldmann F; Saturday G; Hanley PW; Feldmann H
    Lancet Microbe; 2023 Mar; 4(3):e171-e178. PubMed ID: 36739878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From bench to almost bedside: the long road to a licensed Ebola virus vaccine.
    Wong G; Mendoza EJ; Plummer FA; Gao GF; Kobinger GP; Qiu X
    Expert Opin Biol Ther; 2018 Feb; 18(2):159-173. PubMed ID: 29148858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
    Su QD; He SH; Yi Y; Qiu F; Lu XX; Jia ZY; Meng QL; Fan XT; Tian RG; Audet J; Qiu XG; Bi SL
    Vaccine; 2018 Oct; 36(41):6053-6060. PubMed ID: 30195490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms.
    O'Donnell K; Marzi A
    Expert Rev Vaccines; 2020 Mar; 19(3):267-277. PubMed ID: 32129120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.